Signs of impaired immunoregulation and enhanced effector T-cell responses in the primary antiphospholipid syndrome.

Abstract excerpt

INTRODUCTION: We investigated whether primary antiphospholipid syndrome (PAPS) is characterized by a deficiency in immunoregulatory pathways, a phenomenon recently implicated in the pathogenesis of autoimmune diseases. METHODS: Serum levels of immunoregulatory (e.g., IL-10 and TGF-β1) and proinflammatory (e.g., IL-17A) cytokines were measured in PAPS, systemic lupus erythematosus (SLE) with secondary APS (SAPS),...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibodies, Antiphospholipid
• Share to Antiphospholipid Syndrome